Amarin Corp Plc (AMRN)

[ziploc_1]

study..."QUOTE..."Why not settle with Healthnet now when we can still get some type of value especially if we have a generic on the market by second half of this year."

I agree that Amarin needs an authorized generic soon...but but it would advantageous for Amarin to be bought by a BP with a generic arm before marketing a generic Vascepa...rather than than to compete against many generic companies with hundreds of other generic products already on the market...and who have been been making deals with insurance companies to insure that their generic products get sold on a preferred basis.

I believe Denner is the person to manage this sale of Amarin to a BP